What Analyst Projections for Key Metrics Reveal About Crown Castle (CCI) Q3 Earnings — Positive

CCI   Zacks Investment Research — October 17, 2025

Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Crown Castle (CCI), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended September 2025.

image for news What Analyst Projections for Key Metrics Reveal About Crown Castle (CCI) Q3 Earnings

Countdown to Halliburton (HAL) Q3 Earnings: A Look at Estimates Beyond Revenue and EPS — Positive

HAL   Zacks Investment Research — October 17, 2025

Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Halliburton (HAL), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended September 2025.

image for news Countdown to Halliburton (HAL) Q3 Earnings: A Look at Estimates Beyond Revenue and EPS

Countdown to GE Vernova (GEV) Q3 Earnings: Wall Street Forecasts for Key Metrics — Neutral

GEV   Zacks Investment Research — October 17, 2025

Evaluate the expected performance of GE Vernova (GEV) for the quarter ended September 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.

image for news Countdown to GE Vernova (GEV) Q3 Earnings: Wall Street Forecasts for Key Metrics

Besides Wall Street's top-and-bottom-line estimates for Kinder Morgan (KMI), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended September 2025.

image for news Stay Ahead of the Game With Kinder Morgan (KMI) Q3 Earnings: Wall Street's Insights on Key Metrics

Evaluate the expected performance of Amphenol (APH) for the quarter ended September 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.

image for news Seeking Clues to Amphenol (APH) Q3 Earnings? A Peek Into Wall Street Projections for Key Metrics

Ahead of Packaging Corp. (PKG) Q3 Earnings: Get Ready With Wall Street Estimates for Key Metrics — Positive

PKG   Zacks Investment Research — October 17, 2025

Beyond analysts' top-and-bottom-line estimates for Packaging Corp. (PKG), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended September 2025.

image for news Ahead of Packaging Corp. (PKG) Q3 Earnings: Get Ready With Wall Street Estimates for Key Metrics

AT&T (T) Q3 Earnings Preview: What You Should Know Beyond the Headline Estimates — Neutral

T   Zacks Investment Research — October 17, 2025

Get a deeper insight into the potential performance of AT&T (T) for the quarter ended September 2025 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.

image for news AT&T (T) Q3 Earnings Preview: What You Should Know Beyond the Headline Estimates

Curious about Lennox (LII) Q3 Performance? Explore Wall Street Estimates for Key Metrics — Neutral

LII   Zacks Investment Research — October 17, 2025

Get a deeper insight into the potential performance of Lennox (LII) for the quarter ended September 2025 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.

image for news Curious about Lennox (LII) Q3 Performance? Explore Wall Street Estimates for Key Metrics

Teledyne (TDY) Q3 Earnings Preview: What You Should Know Beyond the Headline Estimates — Positive

TDY   Zacks Investment Research — October 17, 2025

Besides Wall Street's top-and-bottom-line estimates for Teledyne (TDY), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended September 2025.

image for news Teledyne (TDY) Q3 Earnings Preview: What You Should Know Beyond the Headline Estimates

ETHA, The Best Risk-Reward Opportunity In All Of Crypto? — Positive

ETHA   Seeking Alpha — October 17, 2025

As Ether becomes institutionalized, I believe the BlackRock ETHA ETF to be the least risky way to own this asset. Driven by the tokenzation theme, I think Ether has some way up to go yet - we have a target price range of $42-49. A break below $28 would render our thesis bunk.

image for news ETHA, The Best Risk-Reward Opportunity In All Of Crypto?

Gold Price Outlook – Gold Looks a Bit Tired on Friday — Neutral

AAAU  BAR  DBP  DGL  GLD  GLDM  IAU  OUNZ  SGOL  UGL   FXEmpire — October 17, 2025

The gold market continues to see a lot of noise, and at this point, it looks like we are finally seeing a bit of gravity. This market is still very strong, and as a result, I think this is a situation where, eventually, we are going to see a big

image for news Gold Price Outlook – Gold Looks a Bit Tired on Friday

15% of a Portfolio in Gold? Billionaire Ray Dalio Thinks It's a Good Idea — Neutral

GLD   24/7 Wall Street — October 17, 2025

The bull market in gold really is something special, with the precious metal adding another 2.4% yesterday when the S&P 500 plunge by 0.6%.

image for news 15% of a Portfolio in Gold? Billionaire Ray Dalio Thinks It's a Good Idea

WST Q3 Earnings Preview: Can GLP-1 Momentum Outweigh Margin Pressure? — Positive

WST   Zacks Investment Research — October 17, 2025

West Pharma's Q3 numbers hinge on robust GLP-1 and biologics demand, but labor constraints, tariffs, and plant shutdowns could test its margin resilience.

image for news WST Q3 Earnings Preview: Can GLP-1 Momentum Outweigh Margin Pressure?

Intuitive Surgical Pre-Q3 Analysis: Buy, Hold or Sell ISRG Stock Now? — Neutral

ISRG   Zacks Investment Research — October 17, 2025

Intuitive Surgical enters Q3 earnings season on strong momentum, backed by robust procedure growth and da Vinci 5 adoption. However, tariff risks and global CapEx constraints remain challenges.

image for news Intuitive Surgical Pre-Q3 Analysis: Buy, Hold or Sell ISRG Stock Now?

Praxis Precision Medicines (PRAX) Surges 183.7%: Is This an Indication of Further Gains? — Positive

PRAX   Zacks Investment Research — October 17, 2025

Praxis Precision Medicines (PRAX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

image for news Praxis Precision Medicines (PRAX) Surges 183.7%: Is This an Indication of Further Gains?

Why Micron is pulling out of the data-center chip business in China — Negative

MU   Market Watch — October 17, 2025

The memory-chip maker reportedly hasn't recovered from a Chinese government ban on part of its chip business in 2023.

image for news Why Micron is pulling out of the data-center chip business in China

Goldman Sachs upgrades Thomson Reuters to ‘Buy,' sees over 20% upside on AI strength — Positive

TRI   Proactive Investors — October 17, 2025

Goldman Sachs Group Inc (NYSE:GS, ETR:GOS) has upgraded Thomson Reuters (NYSE:TRI) to ‘Buy' from ‘Neutral', saying the information services company's deepening integration of generative AI across its legal, tax and corporate software businesses positions it for sustained growth and multiple expansion. The bank set a 12-month price target of $186 for Thomson Reuters' US-listed shares, which is more than 20% upside, and C$258 for its Toronto listing, citing accelerating organic revenue growth and a widening competitive moat anchored by proprietary data and editorial expertise.

image for news Goldman Sachs upgrades Thomson Reuters to ‘Buy,' sees over 20% upside on AI strength

FAS: Significant Risks Warrant A Sell Rating — Negative

FAS   Seeking Alpha — October 17, 2025

Direxion Daily Financial Bull 3X Shares ETF (FAS) is rated a Sell due to six major risks facing financial stocks and the economy. FAS's +3x leverage amplifies downside risk, making it especially vulnerable amid recession, inflation, interest rate, bond, housing, and commercial real estate threats. Technical analysis shows FAS underperforming the S&P 500, with negative momentum and flat price action, signaling caution for leveraged exposure.

image for news FAS: Significant Risks Warrant A Sell Rating

CCL vs. RCL: Which Cruise Stock Deserves a Spot in Your Portfolio? — Positive

CCL  RCL   Zacks Investment Research — October 17, 2025

Carnival gains the edge over Royal Caribbean as its destination-led model, debt reduction and rising yields fuel stronger momentum into 2025.

image for news CCL vs. RCL: Which Cruise Stock Deserves a Spot in Your Portfolio?

TSMC: A Strong Buy At All-Time Highs — Positive

TSM   Seeking Alpha — October 17, 2025

Taiwan Semiconductor Manufacturing Company Limited delivered strong Q3 results, beating expectations with robust revenue growth and expanding gross margins. TSMC dominates the foundry market with over 70% share, benefiting from surging AI chip demand. The company is seeing strong revenue and earnings momentum. Gross margins are rising. The foundry raised its 2025 revenue and CapEx guidance amid a booming AI chip market.

image for news TSMC: A Strong Buy At All-Time Highs